Why Pfizer and Merck Are Fighting to Buy Siegen (NASDAQ:SGEN)

Chess board with wooden blocks of chess pieces and word mergers and acquisitions

Kagukan Saiin

Anticancer drug manufacturer Siegen (NASDAQ:SGEN) reportedly attracted interest from two pharma giants in less than a year, and Horizon Therapeutics (HZNP) sparked a takeover war, and Amgen (AMGN

#Pfizer #Merck #Fighting #Buy #Siegen #NASDAQSGEN